# RAYONIER ADVANCED MATERIALS INC. (RYAM) Informational only - not investment advice. CIK: 0001597672 SIC: 2611 Pulp Mills SIC breadcrumb: [Manufacturing](/division/D/) > [SIC Major Group 26](/major-group/26/) > [SIC 2611 Pulp Mills](/industry/2611/) Latest 10-K filed: 2026-03-05 SEC page: https://www.sec.gov/edgar/browse/?CIK=1597672 Filing source: https://www.sec.gov/Archives/edgar/data/1597672/000159767226000010/ryam-20251231.htm ## At a glance FY2025 · period end 2025-12-31 · filed 2026-03-05 · accession 0001597672-26-000010 · source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001597672.json | Metric | Value | FY | Provenance | | --- | ---: | ---: | --- | | Revenue | 1,466,397,000 USD | 2025 | verified | | Net income | -420,674,000 USD | 2025 | verified | | Assets | 1,758,355,000 USD | 2025 | verified | | Net margin | -28.69% | 2025 | computed | | Operating margin | 0.28% | 2025 | computed | | Revenue YoY | -10.05% | 2025 | computed | | ROE | -132.89% | 2025 | computed | Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity. No market price, no rating, no forecast on this site. Not investment advice. ### Peer percentile fingerprint | Ratio | RYAM | Peer median | Percentile | N | | --- | ---: | ---: | ---: | ---: | | Net margin | -28.7% | 3.1% | 0 | 14 | | Operating margin | 0.3% | 5.5% | 40 | 11 | | Revenue growth | -10.1% | 4.1% | 8 | 14 | | ROE | -132.9% | 8.6% | 0 | 14 | | ROA | -23.9% | 2.7% | 0 | 14 | | Liabilities / equity | 4.55 | 1.97 | 92 | 14 | | Current ratio | 1.58 | 1.54 | 54 | 14 | Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC major-group 26 SIC Major Group 26, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking. ## Selected Fundamentals | Metric | Value | Unit | FY | Filed | | --- | ---: | --- | ---: | --- | | Revenue | 1466397000 | USD | 2025 | 2026-03-05 | | Net income | -420674000 | USD | 2025 | 2026-03-05 | | Assets | 1758355000 | USD | 2025 | 2026-03-05 | ## Financials Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-03-05. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001597672.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts. | Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | | | 940,416,000 | 1,956,994,000 | 1,430,948,000 | 1,343,834,000 | 1,407,558,000 | 1,717,267,000 | 1,643,330,000 | 1,630,308,000 | 1,466,397,000 | | Net income | | 73,286,000 | 324,964,000 | 128,416,000 | -22,450,000 | 555,000 | 66,414,000 | -14,919,000 | -101,835,000 | -38,744,000 | -420,674,000 | | Operating income | | 137,647,000 | 58,980,000 | 147,815,000 | -52,483,000 | -30,365,000 | -10,445,000 | 26,135,000 | -65,264,000 | 39,481,000 | 4,098,000 | | Gross profit | | 181,273,000 | 140,753,000 | 291,147,000 | 53,465,000 | 63,429,000 | 74,722,000 | 123,083,000 | 88,154,000 | 165,582,000 | 118,785,000 | | Diluted EPS | | 1.55 | 5.81 | 1.96 | -0.57 | 0.01 | 1.05 | -0.23 | -1.57 | -0.59 | -6.33 | | Operating cash flow | | 232,225,000 | 129,772,000 | 246,944,000 | 41,904,000 | 124,470,000 | 233,224,000 | 68,813,000 | 136,274,000 | 203,610,000 | 23,911,000 | | Assets | 1,278,612,000 | 1,421,939,000 | | 2,679,086,000 | 2,480,147,000 | 2,529,865,000 | 2,445,024,000 | 2,347,528,000 | 2,182,700,000 | 2,129,657,000 | 1,758,355,000 | | Stockholders' equity | | 211,749,000 | 693,756,000 | 706,871,000 | 682,798,000 | 695,087,000 | 814,343,000 | 829,313,000 | 746,447,000 | 713,885,000 | 316,556,000 | | Cash and cash equivalents | 101,303,000 | 326,655,000 | | 108,966,000 | 64,025,000 | 93,653,000 | 253,307,000 | 151,803,000 | 75,768,000 | 125,222,000 | 75,393,000 | ### Ratios ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported. | Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Net margin | | | 34.56% | 6.56% | -1.57% | 0.04% | 4.72% | -0.87% | -6.20% | -2.38% | -28.69% | | Operating margin | | | 6.27% | 7.55% | -3.67% | -2.26% | -0.74% | 1.52% | -3.97% | 2.42% | 0.28% | | Return on equity | | 34.61% | 46.84% | 18.17% | -3.29% | 0.08% | 8.16% | -1.80% | -13.64% | -5.43% | -132.89% | | Return on assets | | 5.15% | | 4.79% | -0.91% | 0.02% | 2.72% | -0.64% | -4.67% | -1.82% | -23.92% | | Liabilities / equity | | 5.72 | | 2.79 | 2.63 | 2.64 | 2.00 | 1.83 | 1.92 | 1.98 | 4.55 | | Current ratio | 2.49 | 4.09 | | 1.93 | 2.01 | 2.16 | 2.19 | 1.95 | 1.53 | 1.50 | 1.58 | ## As-reported value updates 5 tracked differences above grepcent's stated thresholds were found between the earliest XBRL-filed value and the value currently on file for the same fiscal period. Ledger: /company/RYAM/revisions/ ## Quarterly Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-05. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001597672.json. Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived. | Quarter | End date | Revenue | Net income | Diluted EPS | Method | | --- | --- | ---: | ---: | ---: | --- | | 2022-Q3 | 2022-09-24 | | | 0.45 | reported discrete quarter | | 2023-Q1 | 2023-04-01 | | | 0.02 | reported discrete quarter | | 2023-Q2 | 2023-07-01 | | | -0.26 | reported discrete quarter | | 2023-Q3 | 2023-09-30 | 368,670,000 | -25,100,000 | -0.39 | reported discrete quarter | | 2023-Q4 | 2023-12-31 | 422,486,000 | -61,592,000 | | derived Q4 = FY annual - nine-month YTD | | 2024-Q1 | 2024-03-30 | 387,656,000 | -1,570,000 | -0.02 | reported discrete quarter | | 2024-Q2 | 2024-06-29 | 419,045,000 | 11,390,000 | 0.17 | reported discrete quarter | | 2024-Q3 | 2024-09-28 | 401,103,000 | -32,598,000 | -0.49 | reported discrete quarter | | 2024-Q4 | 2024-12-31 | 422,504,000 | -15,966,000 | | derived Q4 = FY annual - nine-month YTD | | 2025-Q1 | 2025-03-29 | 355,967,000 | -31,970,000 | -0.49 | reported discrete quarter | | 2025-Q2 | 2025-06-28 | 340,048,000 | -363,197,000 | -5.44 | reported discrete quarter | | 2025-Q3 | 2025-09-27 | 352,837,000 | -4,454,000 | -0.07 | reported discrete quarter | | 2025-Q4 | 2025-12-31 | 417,545,000 | -21,053,000 | | derived Q4 = FY annual - nine-month YTD | | 2026-Q1 | 2026-03-28 | 319,065,000 | -81,579,000 | -1.22 | reported discrete quarter | | 2026-Q2 | 2026-06-27 | 376,142,000 | -32,846,000 | -0.49 | reported discrete quarter | ## Filed narrative (10-K & 10-Q) ## Business Verbatim Item 1 Business section from RYAM's latest 10-K: [/company/RYAM/business/](/company/RYAM/business/). ## Risk Factors Verbatim Item 1A Risk Factors from RYAM's latest 10-K: [/company/RYAM/risk-factors/](/company/RYAM/risk-factors/). ## Latest quarter (10-Q) Latest 10-Q source: https://www.sec.gov/Archives/edgar/data/1597672/000159767226000029/ryam-20260627.htm Extracted structurally from real Item 2 body heading to real Item 3/4 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high Filing date: 2026-08-05 Report date: 2026-06-27 Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations The following analysis of our financial condition and results of operations should be read in conjunction with our Financial Statements and the notes thereto included in this Quarterly Report on Form 10-Q and with our 2025 Form 10-K and information contained in subsequent Forms 8-K and other reports filed with the SEC. Forward-Looking Statements Certain statements in this Quarterly Report on Form 10-Q regarding anticipated financial, business, legal or other outcomes, including business and market conditions, outlook and other similar statements relating to future events, developments or financial or operational performance or results, are “forward-looking statements” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. These forward-looking statements are identified by the use of words such as “may,” “will,” “should,” “could,” “expect,” “estimate,” “target,” “believe,” “intend,” “plan,” “forecast,” “anticipate,” “project,” “guidance” and other similar language. However, the absence of these or similar words or expressions does not mean that a statement is not forward-looking. Forward-looking statements are not guarantees of future performance or events and undue reliance should not be placed on these statements. Although we believe the expectations reflected in any forward-looking statements are based on reasonable assumptions, we can give no assurance that these expectations will be attained, and it is possible that actual results may differ materially from those indicated by these forward-looking statements due to various risks and uncertainties. The risk factors contained in Item 1A—Risk Factors of our 2025 Form 10-K, among others, could cause actual results or events to differ materially from our historical experience and those expressed in forward-looking statements made in this report. Forward-looking statements are only as of the date of the filing of this Quarterly Report on Form 10-Q, and we undertake no duty to update forward-looking statements except as required by law. You are advised to review any disclosures that we have made or may make in our filings and other submissions to the SEC, including those on Forms 10-K, 10-Q, 8-K and other reports. Business Overview RYAM is a global leader of high purity cellulose commonly used in the production of filters, food, pharmaceuticals, high performance plastics, propellants and various other industrial applications. Our specialized assets, capable of creating the world’s leading cellulose specialties products, are also used to produce cellulose viscose pulp, cellulose fluff pulp, paperboard, high yield pulp and various value-added co-products, including biofuels, bioelectricity and lignin. New Segment Structure Beginning in January 2026, we reorganized our segment structure and now operate in two segments: •High Purity Cellulose: formerly the segments of Cellulose Specialties, Cellulose Commodities and Biomaterials •Paperboard & High Yield Pulp: formerly the segments of Paperboard and High Yield Pulp Prior period segment results have been recast to align with this new segment reporting structure. See Note 16—Segments for further information. Recent Business Developments •In August 2025, RYAM and USW jointly filed petitions with the USITC and the USDOC alleging that certain Brazilian and Norwegian producers of high purity dissolving pulp are selling into the U.S. market at unfairly low prices and/or benefiting from government subsidies, resulting in material injury to the U.S. industry. In September 2025, the USITC issued an affirmative preliminary injury determination, allowing the investigations to proceed. During the second quarter of 2026, the USDOC issued affirmative preliminary antidumping duty determinations with respect to imports from Brazil and Norway and an affirmative preliminary countervailing duty determination with respect to imports from Brazil. In addition, the USITC scheduled the final phase of the investigations, with final determinations expected later in 2026. While the outcome of these proceedings remains uncertain, we believe the petitions are an important step toward addressing alleged unfair trade practices and supporting more stable and competitive market conditions in the U.S. 21 Table of Contents Separately, during the third quarter of 2026, the Office of the United States Trade Representative announced final Section 301 actions applicable to imports from Brazil and Norway, including an aggregate 37.5% tariff on Brazilian imports of DWP (HTS Code 4702) and a 12.5% tariff on Norwegian imports of DWP. However, the ultimate impact of these actions will depend on a number of factors, including the extent to which downstream customers are able to utilize available trade programs and other regulatory mechanisms applicable to exported products. •In 2025, we signed Memoranda of Understanding with Verso Energy to explore eSAF opportunities at both our Jesup and Tartas facilities. In March 2026, a grant agreement was signed with the European Climate, Infrastructure and Environmental Executive Agency that positions Verso’s ReSTart project (Renewable e-SAF Tartas) to become one of the first large-scale synthetic aviation fuel production plants in Europe through the capture of biogenic CO2 emissions from our Tartas HPC plant. The project aims to contribute to and accelerate the achievement of the aviation sector’s decarbonization targets for 2030 to 2050 as established by various European Union regulatory mandates. Business Outlook Our comprehensive review of strategic alternatives remains the top priority and is progressing with urgency and discipline. The review is focused on evaluating the full range of strategic and financial alternatives available to us and identifying the path that best maximizes value for shareholders. We expect to conclude the review and communicate a clear path forward during the fourth quarter of 2026. While the review is underway, management remains focused on strengthening the performance and value of the business. Our priorities are to advance our Cellulose Specialties leadership strategy, improve operating reliability and asset optimization, generate cash and maintain disciplined capital allocation. We believe stronger commercial execution, operating performance and cash generation enhance RYAM’s value under any potential path. Our second quarter results reflected continued progress against these priorities, including higher CS pricing and improved HPC operating income compared to the prior year quarter. We expect sequential improvement in the second half of 2026, although results may continue to be affected by customer inventory levels, demand conditions, commodity pricing, input cost inflation, logistics costs and geopolitical developments. High Purity Cellulose We expect second-half performance to benefit from continued execution of our CS leadership strategy and improved operating performance. CS volumes are expected to remain below prior year levels, as certain customers continue to manage inventories and ordering patterns, particularly in acetate and ethers. Second-half volumes are expected to improve compared with the first half of the year and remain in line with our expectations. The 21% year-over-year increase in CS pricing during the second quarter reflects the differentiated performance and value that our products deliver across the grades and end markets we serve. We expect CS pricing to remain significantly above prior-year levels through the second half, with full-year pricing aligned with our prior expectations. Our commercial approach remains focused on sustaining the pricing progress achieved to date and recognizing the differentiated performance of our products. We are applying this approach with greater precision across products, markets and customer relationships, while pursuing volume and mix opportunities supported by market conditions. This approach is intended to reinforce our competitive positions, support long-term customer relationships and improve the quality and consistency of earnings. CC volumes are expected to remain elevated as we optimize production and asset loading. Market pricing for fluff and viscose has stabilized, with modest improvement expected through the third quarter. Biomaterials results are expected to improve year over year, supported by improved feedstock availability and stable operating performance at Tartas. Chemicals, logistics and other input costs remain subject to inflationary and geopolitical pressure. We have implemented commercial recovery actions on certain CS products where commercially and contractually appropriate. These actions, together with improving commodity pricing, are expected to partially mitigate current inflationary pressures. 22 Table of Contents Paperboard & High Yield Pulp We expect second-half performance to benefit from tightening PBD industry operating rates, which should support firmer pricing, together with continued growth in higher-value folding packaging products, including freezer board and oil-and-grease-resistant grades. In HYP, the market remains structurally oversupplied and pricing remains challenged; however, we are progressing commercialization of softwood rolled pulp for absorbent-care applications, which should support improved mix and broader participation in differentiated end uses. Additionally, we are actively monitoring evolving trade dynamics, including the recently announced tariff on certain Canadian origin products, and have actionable mitigation plans in place. Corporate & Other We will continue to maintain disciplined control of discretionary spending and pursue structural efficiencies across the organization. Subject to variability in foreign exchange rates, incentive compensation and costs associated with the strategic review, Corporate & Other Adjusted EBITDA is expected to approximate $45 million in 2026, compared with $72 million in 2025. Capital allocation We remain focused on preserving liquidity and financial flexibility while supporting safe and reliable operations. Capital expenditures will continue to be prioritized toward essential maintenance, reliability and initiatives that support near-term cash generation and attractive risk-adjusted returns. Cash generation and deleveraging remain important priorities. We will continue to actively manage working capital, capital spending and operating costs while maintaining appropriate liquidity and compliance with our debt covenants. Results of Operations [Excerpt truncated for page length; source filing is linked above.] ## Latest 10-K MD&A (excerpt) Latest 10-K Item 7 source: https://www.sec.gov/Archives/edgar/data/1597672/000159767226000010/ryam-20251231.htm Complete FY 2025 MD&A: /company/RYAM/mda/fy2025/ Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Published MD&A gate trimmed front/tail over-capture. Confidence: high Filing date: 2026-03-05 Report date: 2025-12-31 Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations The following management’s discussion and analysis of our financial condition and results of operations should be read in conjunction with our Financial Statements, the notes thereto, and the financial information appearing elsewhere in this 2025 Form 10-K. The following discussion includes forward-looking statements that involve certain risks and uncertainties. See Forward-Looking Statements and Item 1A—Risk Factors in this 2025 Form 10-K. This section primarily discusses 2025 and 2024 items and comparisons between these years, with the exception of our “Operating Results by Segment,” which has been recast in line with our new segment reporting structure for all periods presented. For a discussion of all other year-over-year comparisons between 2024 and 2023 and other financial information related to 2023 that is not included in this 2025 Form 10-K, refer to Item 7—Management’s Discussion and Analysis of Financial Condition and Results of Operations of our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 6, 2025. Overview of Operations We are a diversified global leader of cellulose-based technologies, operating in the following segments: •Cellulose Specialties •Biomaterials •Cellulose Commodities •Paperboard •High-Yield Pulp Prior to 2025, the Cellulose Specialties, Biomaterials and Cellulose Commodities operating segments were reported as a single segment, High Purity Cellulose. In the first quarter of 2025, we determined that the performance and outlook of the High Purity Cellulose business would be better managed as three separate businesses. Prior period segment results have been recast to align with this new segment reporting structure. No changes were made to the composition of the Paperboard and High-Yield Pulp operating segments. See Note 22—Segment and Geographical Information to our Financial Statements for further information. In January 2026, we appointed a new CEO who also assumed the role of CODM. Operating segments are determined based on how the CODM reviews and evaluates company operations for purposes of assessing performance and allocating resources. As a result of this leadership transition, we will evaluate whether any changes to our reportable segment structure are required in 2026. Cellulose Specialties We are the leading global producer of cellulose specialties, which are primarily used in dissolving chemical applications that require a highly purified form of cellulose, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. Pricing for our cellulose specialties products is typically set by contract for at least one year, based on negotiations with customers. Key input costs — wood, chemicals and energy — represent approximately 45 percent of our per MT cost of sales. Transportation, depreciation, labor, maintenance and other manufacturing fixed costs represent our remaining cost of sales. Biomaterials Our specialized assets also produce biomaterials, including biofuels, lignosulfonates, tall oil soap, HCE and turpentine. Sales of lignin, a by-product of our manufacturing process, are also included in the Biomaterials operating segment. Commercial sales of our wood-based 2G bioethanol fuel are in accordance with a long-term offtake agreement with a large international petrochemicals company. Pricing for the other biomaterials that we currently produce is based on the market dynamics of supply and demand. Key input costs — chemicals and energy — represent approximately 30 percent of our cost of sales. Transportation, depreciation, labor, maintenance and other manufacturing fixed costs represent our remaining cost of sales. 28 Table of Contents Cellulose Commodities Our Cellulose Commodities products are primarily used for absorbent materials and viscose applications. Absorbent materials, typically referred to as fluff, are used as an absorbent medium in consumer products. Commodity viscose is a raw material required for the manufacture of viscose staple fibers, which are used in woven and non-woven applications. Pricing for commodity products is typically referenced to published indices or based on publicly available spot market prices. Key input costs — wood, chemicals and energy — represent approximately 40 percent of our per MT cost of sales. Transportation, depreciation, labor, maintenance and other manufacturing fixed costs represent our remaining cost of sales. Cellulose Production Facilities Our three operating production facilities, located in the U.S., Canada and France, have a combined annual production capacity of 885,000 MTs of cellulose specialties and commodities products, excluding the 140,000 MTs capacity of the Temiscaming cellulose plant whose operations were indefinitely suspended in July 2024 and permanently ceased DWP production in the first quarter of 2026. Of our total annual capacity, we dedicate 270,000 MTs of annual production to commodities products, primarily fluff. We can shift our cellulose manufacturing assets from cellulose specialties production to cellulose commodity fluff and viscose production. Our operating lines fluctuate the production of cellulose specialties and commodities products based on market conditions and to generate the most attractive margins. Our Tartas cellulose plant and Temiscaming cellulose plant (when operating) also produce bio-generated electricity utilizing renewable biomass. See Note 3—Indefinite Suspension of Operations to our Financial Statements for further information regarding the indefinite suspension of Temiscaming cellulose operations. Paperboard We manufacture Kallima® Coated Cover Paperboard that is used for packaging, printing documents, brochures, promotional materials, paperback book and catalog covers, file folders, tags and lottery tickets. Pricing for paperboard is typically referenced to published indices and marketed through our internal sales team. Our production facility, located in Canada, has an annual production capacity of 180,000 MTs of paperboard. Key input costs — wood pulp, chemicals and energy — represent approximately 50 percent of our per MT cost of sales. Transportation, depreciation, labor, maintenance and other manufacturing fixed costs represent our remaining cost of sales. High-Yield Pulp We manufacture high-yield pulp, which paper manufacturers use to produce paperboard, packaging, coated and uncoated printing and writing paper, specialty papers and various other paper products. Pricing for high-yield pulp is typically referenced to published indices marketed through our internal sales team. Our production facility in Temiscaming has an annual production capacity of 290,000 MTs of high-yield pulp. Key input costs — wood, chemicals and energy — represent approximately 35 percent of our per MT cost of sales. Transportation, depreciation, labor, maintenance and other manufacturing fixed costs represent our remaining cost of sales. Recent Business Developments •In August 2025, RYAM and USW jointly filed petitions with the USITC and the USDOC alleging that Brazilian and Norwegian producers of HPDP are selling into the U.S. market at unfairly low prices or with the benefit of government subsidies, causing material injury to the U.S. HPDP industry and its workers. In September 2025, the USITC issued an affirmative injury determination, advancing the case to the USDOC, where preliminary determinations are expected in the first half of 2026. The USITC’s decision represents an important step toward restoring fair competition in the U.S. market and promoting greater pricing stability going forward. •In October 2025, we expanded our Kallima® portfolio with the introduction of an enhanced freezer application for folding carton board. This innovation comes as the frozen food market continues to grow worldwide, driven by consumer demand for convenience and extended shelf life. With the Enhanced Freezer Application, RYAM provides packaging manufacturers with a solution that safeguards product integrity while delivering on sustainability and operational efficiency. 29 Table of Contents Business Outlook 2025 was a challenging year for RYAM, with results impacted by various disruptions and a difficult demand environment. As we enter 2026, our message is simple: restore positive free cash flow and sharpen the organization’s focus on disciplined execution. In 2026, our priorities are clear: •Deliver positive free cash flow and exit 2026 with building momentum •Assert our leadership in Cellulose Specialties •Drive year-over-year EBITDA improvement across every business Our outlook is directional and centered on execution, cash discipline and measurable improvement across the portfolio. Cellulose Specialties We expect improvement to be driven by disciplined commercial execution, including pricing actions that reflect the value of our products. Volumes are expected to be pressured early in 2026 as customers adjust ordering and inventory positions, with improvement building as the year progresses. The focus remains on execution, service and cash conversion. Biomaterials Our near-term focus is operational execution to support improved feedstock availability and stable performance at our existing bioethanol operations. We will continue to evaluate additional Biomaterials projects with a disciplined lens on returns and execution risk. Cellulose Commodities Market conditions remain challenging, particularly in fluff, with continued weakness tied to China dynamics. We will continue to run the business with a focus on reliability, cost control and disciplined working capital, while navigating demand variability across commodity grades. We will also look to drive incremental value where we have the ability to do so, including through pricing, mix and commercial actions across the commodity portfolio. Paperboard We expect year-over-year improvement to be supported by new product commercialization and volume increases, with pricing stabilizing as supply and demand dynamics improve, alongside continued operational and cost discipline. High-Yield Pulp We expect year-over-year improvement to be supported by new product commercialization, with these products carrying premium pricing as we expand into higher-value end markets. Corporate / Other We will maintain strict control of discretionary spending and continue driving structural efficiencies, with a focus on supporting cash generation and execution across the businesses. Capital allocation We remain committed to disciplined capital allocation and liquidity management. We will prioritize and reduce capital expenditures with a focus on near-term cash generation and deleveraging and will continue to evaluate capital return options within our capital allocation framework as performance and financial flexibility improve. See Performance and Liquidity Indicators below for a discussion of non-GAAP financial measures. 30 Table of Contents Results of Operations [Excerpt truncated for page length; the complete text is on the linked full-MD&A page.] Read the full FY 2025 MD&A: /company/RYAM/mda/fy2025/ All MD&A years: /company/RYAM/mda/ ## MD&A history Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page. - [FY 2024 MD&A](/company/RYAM/mda/fy2024/): filed 2025-03-06; accession 0001597672-25-000008 (https://www.sec.gov/Archives/edgar/data/1597672/000159767225000008/ryam-20241231.htm) - [FY 2023 MD&A](/company/RYAM/mda/fy2023/): filed 2024-02-29; accession 0001597672-24-000006 (https://www.sec.gov/Archives/edgar/data/1597672/000159767224000006/ryam-20231231.htm) - [FY 2022 MD&A](/company/RYAM/mda/fy2022/): filed 2023-03-01; accession 0001597672-23-000013 (https://www.sec.gov/Archives/edgar/data/1597672/000159767223000013/ryam-20221231.htm) - [FY 2021 MD&A](/company/RYAM/mda/fy2021/): filed 2022-03-01; accession 0001597672-22-000011 (https://www.sec.gov/Archives/edgar/data/1597672/000159767222000011/ryam-20211231.htm) ## Macro cross-references Indicators mapped to this company's SIC classification (industry 2611 Pulp Mills) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim. - [INDPRO](/indicator/INDPRO/): Industrial Production: Total Index - [TCU](/indicator/TCU/): Capacity Utilization: Total Index - [PPIACO](/indicator/PPIACO/): Producer Price Index by Commodity: All Commodities - [GDPC1](/indicator/GDPC1/): Real Gross Domestic Product - [DGS10](/indicator/DGS10/): Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity - [FEDFUNDS](/indicator/FEDFUNDS/): Federal Funds Effective Rate - [CES0500000003](/indicator/CES0500000003/): Average Hourly Earnings of All Employees, Total Private - [PAYEMS](/indicator/PAYEMS/): All Employees, Total Nonfarm Macro-to-micro threads including this sector: [Inflation (CPI / PCE / PPI)](/thread/inflation-cpi-pce-ppi/), [US labor market](/thread/us-labor-market/), [Growth & output](/thread/growth-output/), [Money & trade](/thread/money-trade/), [Government finances](/thread/government-finances/), [Sector employment](/thread/sector-employment/), [Industrial orders & inventories](/thread/industrial-orders/), [Trade & external](/thread/trade-external/). All macro indicators: /indicators/ ## For LLMs & downloads Markdown twin: /company/RYAM.md · JSON record: /company/RYAM.json · verified financials: /company/RYAM/financials.json / /company/RYAM/financials.csv · machine TOC for the whole site: /llms.txt